Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 42% ± 20% | |
peripheral blood | 13 studies | 27% ± 10% | |
lung | 12 studies | 27% ± 9% | |
eye | 10 studies | 35% ± 15% | |
kidney | 7 studies | 22% ± 6% | |
intestine | 6 studies | 21% ± 7% | |
heart | 5 studies | 28% ± 6% | |
bone marrow | 4 studies | 22% ± 4% | |
liver | 4 studies | 30% ± 12% | |
adipose | 4 studies | 39% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 14776.53 | 1445 / 1445 | 100% | 60.14 | 183 / 183 |
lung | 100% | 15519.67 | 578 / 578 | 100% | 58.62 | 1155 / 1155 |
prostate | 100% | 15080.21 | 245 / 245 | 100% | 79.82 | 502 / 502 |
uterus | 100% | 16858.64 | 170 / 170 | 100% | 62.83 | 459 / 459 |
brain | 100% | 15744.31 | 2641 / 2642 | 100% | 93.10 | 705 / 705 |
breast | 100% | 17513.50 | 459 / 459 | 100% | 102.65 | 1117 / 1118 |
thymus | 100% | 15348.82 | 653 / 653 | 100% | 92.12 | 604 / 605 |
bladder | 100% | 15735.62 | 21 / 21 | 100% | 57.15 | 503 / 504 |
kidney | 100% | 11189.10 | 89 / 89 | 100% | 86.19 | 898 / 901 |
adrenal gland | 100% | 8735.51 | 258 / 258 | 99% | 57.70 | 227 / 230 |
intestine | 100% | 16313.57 | 966 / 966 | 99% | 52.14 | 520 / 527 |
pancreas | 99% | 6508.20 | 325 / 328 | 99% | 63.31 | 177 / 178 |
liver | 100% | 6501.91 | 226 / 226 | 98% | 35.18 | 398 / 406 |
stomach | 100% | 10087.57 | 359 / 359 | 98% | 49.83 | 280 / 286 |
skin | 100% | 17570.12 | 1809 / 1809 | 96% | 52.08 | 454 / 472 |
ovary | 100% | 17507.39 | 180 / 180 | 96% | 38.14 | 411 / 430 |
blood vessel | 100% | 17748.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 75.09 | 29 / 29 |
spleen | 100% | 20470.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.72 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.58 | 1 / 1 |
adipose | 100% | 17209.57 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 8645.59 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 9842.27 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 13214.69 | 902 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 42.94 | 71 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006517 | Biological process | protein deglycosylation |
GO_0006044 | Biological process | N-acetylglucosamine metabolic process |
GO_0009100 | Biological process | glycoprotein metabolic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0006516 | Biological process | glycoprotein catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0016231 | Molecular function | beta-N-acetylglucosaminidase activity |
GO_0102571 | Molecular function | [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity |
GO_0004415 | Molecular function | hyalurononglucosaminidase activity |
GO_0042802 | Molecular function | identical protein binding |
Gene name | OGA |
Protein name | O-GlcNAcase Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT) |
Synonyms | MGEA5 KIAA0679 HEXC MEA5 |
Description | FUNCTION: [Isoform 1]: Cleaves GlcNAc but not GalNAc from O-glycosylated proteins . Deglycosylates a large and diverse number of proteins, such as CRYAB, ELK1, LMNB1 and TAB1 . Can use p-nitrophenyl-beta-GlcNAc and 4-methylumbelliferone-GlcNAc as substrates but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro) . Does not bind acetyl-CoA and does not have histone acetyltransferase activity . .; FUNCTION: [Isoform 3]: Cleaves GlcNAc but not GalNAc from O-glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc as substrate but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro), but has about six times lower specific activity than isoform 1. . |
Accessions | ENST00000439817.5 [O60502-4] ENST00000357797.9 [O60502-2] ENST00000361464.8 [O60502-1] ENST00000370094.7 [O60502-3] O60502 H7C3X0 ENST00000429860.1 |